Ciencia Technology

Exciting news! Our Senior Scientist Dr. Kelvin Kwok will be attending the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) between 7-10 November in Portugal. In this meeting, Dr. Kwok will present two posters, sharing our latest findings in the treatment patterns and outcomes in patients with bladder cancer (HR-NMIBC and MIBC) using linked data from Swedish population-based registers and patient electronic medical record. We look forward to seeing you at the congress!

✨ We’re Live! Explore Schain Research’s New Website ✨ Our new website is now live at www.schainresearch.com! At Schain Research, we specialize in Real-World Evidence (RWE), offering expert services in evidence generation and health data analysis. We support life science companies across a broad range of therapeutic areas, helping them leverage RWE to make informed decisions, evaluate treatment effectiveness, and guide strategic initiatives. When working with us, you can expect seamless collaboration and high-quality research that drives impactful outcomes. Interested in learning more? Take a sneak peek and contact us directly through the site. 👉 Visit us today: www.schainresearch.com

More SR news! We are excited to announce that our senior scientist Dr. Kelvin Kwok will be attending the Society of Maternal Fetal Medicine (SMFM) Global Congress 2024 between 25-28 September in Italy. He will be presenting two posters for a register-based RWE study, which examined the characteristics and outcomes of pregnancies at risk of hemolytic disease of fetus and newborn (HDFN) in Sweden, Finland, and Denmark. We look forward to meeting you at the congress and discussing opportunities to support your evidence generation strategies using Nordic real-world data.

I am super excited to represent Schain Research at the 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗠𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗙𝗲𝘁𝗮𝗹 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 (𝗦𝗠𝗙𝗠) 𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟰 in Rome this month! I will be presenting 𝘁𝘄𝗼 𝗽𝗼𝘀𝘁𝗲𝗿𝘀: • (168) 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘤𝘩𝘢𝘳𝘢𝘤𝘵𝘦𝘳𝘪𝘴𝘵𝘪𝘤𝘴 𝘢𝘯𝘥 𝘱𝘳𝘦𝘨𝘯𝘢𝘯𝘤𝘺 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘪𝘯 𝘱𝘳𝘦𝘨𝘯𝘢𝘯𝘤𝘪𝘦𝘴 𝘢𝘵 𝘳𝘪𝘴𝘬 𝘰𝘧 𝘏𝘋𝘍𝘕 𝘪𝘯 𝘚𝘸𝘦𝘥𝘦𝘯, 𝘍𝘪𝘯𝘭𝘢𝘯𝘥, 𝘢𝘯𝘥 𝘋𝘦𝘯𝘮𝘢𝘳𝘬 • (169) 𝘙𝘦𝘵𝘳𝘰𝘴𝘱𝘦𝘤𝘵𝘪𝘷𝘦 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴 𝘰𝘧 𝘯𝘦𝘰𝘯𝘢𝘵𝘢𝘭 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘪𝘯 𝘱𝘳𝘦𝘨𝘯𝘢𝘯𝘤𝘪𝘦𝘴 𝘢𝘵 𝘳𝘪𝘴𝘬 𝘰𝘧 𝘏𝘋𝘍𝘕 𝘪𝘯 𝘚𝘸𝘦𝘥𝘦𝘯, 𝘍𝘪𝘯𝘭𝘢𝘯𝘥, 𝘢𝘯𝘥 𝘋𝘦𝘯𝘮𝘢𝘳𝘬 Using data from population-based registers, this multi-national study not only provides a broad overview of the perinatal characteristics and outcomes of pregnancies at risk of hemolytic disease of fetus and newborn (HDFN), but also offers insights into variations in clinical management of this rare condition across the Nordic region. Looking forward to the exciting talks and meeting colleagues and collaborators! #SMFMGlobal24 #MaternalFetalMedicine #Alloimmunization #HDFN #RWE 

🚀 Exciting Opportunity Alert! 🚀 Our team is growing, and we're on the lookout for talented RWE Consultants and Senior RWE Consultants with 3-5 years of experience. If you're passionate about real-world evidence and eager to make an impact, we'd love to hear from you! 📌 Apply now and join us in shaping the future of healthcare! #Hiring #RWE #Consulting #HealthcareCareers

Big news for our company this month as we a few weeks ago welcomed Pernilla Meijer to our team! Schain Research AB, Ciencia Technology AB, and Ciencia AB are pleased to announce the appointment of Pernilla Meijer as the new Chief Executive Officer. With over 20 years of experience in the pharmaceutical industry, Pernilla is a seasoned business executive known for her ability to build, scale, and transform organizations. Throughout her career, Pernilla has led diverse teams at global, regional, and local levels, driving business growth through strategic product launches and creating significant value across the healthcare sector. Her deep understanding of both customer and patient needs has consistently translated into successful business strategies that position companies as leaders in their markets. As CEO, Pernilla combines her extensive expertise in market access, commercial excellence, and advanced technology solutions to drive innovation and sustainable growth. She also has a proven track record in building and expanding consultancy businesses, enabling organizations to deliver innovative, customer-centric solutions. Her leadership is characterized by a clear strategic vision, a hands-on approach to achieving results, and a deep commitment to cultivating healthy, engaged, and high-performing teams. "Pernilla Meijer’s proven track record in transforming and scaling businesses makes her the ideal leader to guide our companies into the future," said Lars Johansson, Chairman of the Board. "Her deep knowledge of market dynamics and her commitment to innovation will be instrumental in expanding our reach and impact in the global healthcare market."

To my RWE, Medical, Market Access and R&D network, and to all of you who asked me about the companies I just joined! Proud to Announce My New Role as Group CEO of Ciencia AB, Schain Research AB, and Ciencia Technology AB.   Our companies specialize in high-quality Real-World Evidence (RWE) services, including clinical and health economic outcomes research, RWE strategy support, and data visualization platforms for the pharmaceutical industry. Our expert team brings extensive experience in research and real-world evidence, helping pharmaceutical companies understand real-world outcomes, enhance decision-making, improve patient outcomes, and accelerate access to cost-effective treatments. We cover a broad range of therapeutic areas, including oncology, immunology, and rare diseases, to provide comprehensive insights and support. We employ both quantitative and qualitative RWE methodologies and offer data visualization services to help clients better understand patient populations and treatment patterns by facilitating access to individual-level patient data. With deep experience navigating the complex process of accessing unique Nordic data for global applications and substantial knowledge of international RWD, we provide robust evidence for R&D, medical affairs, and market access, supporting regulatory submissions and reimbursement decisions. As I embark on this new journey, I am eager to connect with my network and industry professionals who can benefit from our comprehensive RWE solutions. Whether you are part of a global team or a local entity, we can help you make informed decisions and drive impactful outcomes. Reach out to learn more about how our research-driven team can assist you. Contact me on LinkedIn or via email: pernilla@schainresearch.com. Looking forward to potential collaborations and driving innovation together!

We have now integrated with ClinicalTrials.gov in order to filter and display all clinical trials right next to the patient-level data in #EpiX. This continues our mission to provide our clients with data at their fingertips!

We now have data coverage for 1849 ATC codes, pertaining to dispensations across the entire Swedish population, in EpiX! Longitudinal and regional trends of drug dispensations are instantly available to explore in the system.

We now have data coverage for 1849 ATC codes, pertaining to dispensations across the entire Swedish population, in EpiX! Longitudinal and regional trends of drug dispensations are instantly available to explore in the system.